{"ticker": {"uuid": "19b8f0a3-d8fd-4997-831e-0701775ba60c", "symbol": "AFT", "name": "AFT Pharmaceuticals Limited", "exchange": "NZE", "country": "NZ", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "AFT Pharmaceuticals' (NZSE:AFT) Profits Appear To Have Quality Issues", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solid Earnings May Not Tell The Whole Story For AFT Pharmaceuticals (NZSE:AFT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQTThja3ZIbUZOOGk3LWJQdTd5ODdZMy04cjU4YW90Qk5ndnk2ZHBtcnY4QkFiZjNKYVo5bnNPZzMyMjFwNXpWb3pUdElYNF9FR252U1gtNG5kVXRmMFdfcTY2MGlLN1laWjZ3Y3VHUXlTa2duZW9PZ19ORmpwOHNkMVhVaVVmTWhldUJQUHZrb3hqQ1dyd0tF?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Miss: AFT Pharmaceuticals Limited Missed EPS By 6.7% And Analysts Are Revising Their Forecasts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOeGNyWGVCVHcxRkdHZGNxejdxckFMZU1zYXJieHhrenBRYTZ6SExUN0lsc3NQVmc1U2hGajVrQXg2MjZlREE4ZVB2UEx6c1BReDJGZVFvZ3BfM29OUllsWGpfV1JUQ3NmbmRRZkxZWWkxS3U0ODR6RzFScU16UmZJQlVUUG5qRm5fdE4wckFnQ1RGRHJ1bUhjaWFIeGJ6X0JBRDdtX2RJNnNzZw?oc=5", "source_name": "Market source", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFT Pharmaceuticals (NZSE:AFT) EPS Rebound Tests Premium P/E And Non Cash Earnings Concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxPN0lwR0F6eTNtNlRnRDR6bkwyWFNpV21RM2tvU0dpM0JWM3JqQ2F0Sk9lRWZYYUk2SmdmOGpybWlIdW9ROXhfSVZOTmlrOUNWOGZ1X21EZVAxeVJQeHdtdTd3ZTU0VmZweFVUd09GbnJIZTM5anQ5ckFyY2R5WmFOZExfbkw1UDhIMUpUVWpZSEtBMl9mWkc5ODVHYWdDNDN5Z25kd01YVU16djBCTUpicUo0REl3YXBXQ3lrQnNNcVVTcHlEMUtoRWpBV19LOWZzTXpRem0wYTVqOXozd2xzZF9CdGNuNEhock5TT9IB8gFBVV95cUxOb19UOVk5dTFjRWsxbGktbFFmOVhpTDdsMWZpRXhDSDJONm0taGxfZVJJZXpabkpnVHE0aW1ON1NoVTdxVlk4OGJITVlva1BJdDByRG5aVGtlUTJmRXdlSm9nUFdPX2hNNnotTVJjMTVDbUlHSUotUkVCaXk2dC1vb1BFS1J6UHZEMlA4UVQzSk5JSFEzRnByZFlxRFY2TmFOQm1qUG9hWl9rMzRJQ1B5TjlyZVhuLWNqaUlDYmtQLXZrQlNrNkQyRy1sQjBsVHpqbUxFbUVSUVdvaUZHWldBcW43aHRoazJ5TE9EaGJYTm12dw?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFT Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We Think AFT Pharmaceuticals (NZSE:AFT) Is Well Worth Watching", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFT Pharmaceuticals lifts its 2027 revenue target to above $300 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNZ2NjRFBXMGxTVXRScjVUUmdwYjZQVl9naV9fMnFNeUh2Ynp6aXNDRXZMOWNiVXA5alZ4c2d2OGJQTlVkdEUzVTgzUjl1dmpVeGZyMGhmYnFZOHk2VEF5VkRzWHU0LXJNNlkxeXNucGhLT2pITHNlM05KNzdCSldWc0dIWlNZSUFLZzlOdnFJb1hjYzMxdHFHWEhtUUhaUmFESHFqa0NGUHpzSEVNUzEzZUJBdw?oc=5", "source_name": "RNZ", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFT Pharmaceuticals Targets Minimum $300m Revenue After Record Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOeWktbm9CTkVpVWotaFJBWkN2S3poUkNMYUQ2cVVqb3V4SzhnaGV1cER6MTI2S1FJakIwS1JjVkVEMXdaTHFyYnNQRE9tMFFBdk9JMGVCbXk2ZmhNZ0t4TWtZYm9Udk5QdEplM0ZTbE5IbzdZdGVwNFJqRXFZUFh4QXAyU0F6MWpxOUhmS0tadXpFeXZ3Z0l3UkpteU0tVU1KdTVTdlpoRGM3TXFidVE?oc=5", "source_name": "smallcaps.com.au", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFT Pharmaceuticals targets FY27 revenue above NZ$300 mln", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQQ2hqRUZ3bHZaTFNTMl80eUZUczhJQlJmQktveV9iLUNuWlEwSHA4cDQ1al9aVm5RWndGR0xlZXpwX3VUSF9UR0ttZUUxUDBSdTItNDhWazkwZS1tSDhFSG5xVnpBSS1Ia2dsWEVUQkR3S0R0dkIwblRzUm1IT2hEN3ozTVpSYTQ2bnJ1WlEzSzFVVVU4Smw1d1R4cGNPcGFrcG1CZEE1M2Y0NFJ0RGVR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFT Pharmaceuticals appoints new CFO to support global growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNeXlhM184Tk5oTHdPMmMtVHM4RUotVmJ1WWZSX1M2b3pTNWVHV3BfcUFvbmxWR29CWDVwdXdOUlFNT3ZpaGpkSDI5ZDdCVnVUUmV4aWs4cy1iSHo0MDlWNDNZcDQwU25XOUZpbUw1UEVzek5tN2dyd2hZSWxtc3hFLWVUQVR4SFhhdHJHb1k4MHlMajJFdDM5SC1QaW9pX19PMDI5dE9HYlJDOEVfOHNxNnljRnlwV0IyWVRMcGJaWnNRV2lXaUIzTnVTQXVhZ3BVX3ZiY2tyb0R5dw?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Zealand Shares Fall; AFT Pharmaceuticals Appoints CFO", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNVVVhdFVJenItU196SzNXVkkzdVVFUmFzN095OXg3TjBqTVRzRV9Kak95NjJ1VXRkQmt1R0ZIZG02TG1tQTVrRzljcTRDZGVkOV9xUkFiQkdnUWZXNkpCdXpabWhuTlFpazZIdHNHbmZtbVNYYjlIbUFwSDFvdzZWWWVLSzQ0WHdjcW13b3pQMTFDQWdTdUk1aUtFQ1ZxR2c?oc=5", "source_name": "Moomoo", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX2ZfWkxLZDAyQUZNRU55RXhPVHI4dlZrTVVuc3RlV01XV0Jqd21vSDdYU0l3QkJOejBicXhjRXhQcmpkZHlVQ3BsRFE5ZFFxbFV3MWgtLUpndEZKTm1vbTAwaGlYMHEzWVVjNDVUYjFpM1hJS0NRTjdCc3pOeG9VNlg0QThScXpuV3lYNi0xY2NXMnkwdkFMYU8xYWU0WTIyaVdESzRVV2wxaThRazh6bTZCV1RPMWpJWW0tZy1qQUJVNjh6?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why AFT Pharmaceuticals (NZSE:AFT) Has Caught The Eye Of Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPOGdCc2VHQl9hLTVQSFdPZVJEOHZuTWdvRExhWGxES3ZVOHN5XzlTaExMdVIycnRVR0FtblZIQjhtUE1pYk1RRkpKV014cFhTNmVWWkcyQ18xcnlYT01NamVMaU53NlF1eFJNek5DRENZZU0zSTFnVDdmTFFTRlBEaVJwQVZRSENIZFBWOXczSXVXNE81NlptaFJ6WnJzazBU?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and oncology therapeutics market", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPU3pvVWFDd0ZfazJEODF5YVoyWG1QTXkycFVSblVFdFRaS2RNa3JLMHFaV3JTWFhjMDZ6UEttZFk4TW1pLUxIUlBtTDNrMW9odE9wQWxMbHlsQWVDaGJMeDJNTkJ3WW82Qy1JVWcyNFRYRzB3RFlTQTgwOTQ3UHM3allGNHRVZDFYQTdXcUJmcw?oc=5", "source_name": "Market source", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is AFT Pharmaceuticals (NZSE:AFT) Using Too Much Debt?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-21T08:00:00+00:00", "published_display": "21 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Tell The Story For AFT Pharmaceuticals Limited (NZSE:AFT) As Its Stock Soars 27%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-17T07:00:00+00:00", "published_display": "17 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "69% of AFT Pharmaceuticals Limited (NZSE:AFT) is owned by insiders, and they've been buying recently", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxOVW1zVUZubzJZME5XUk1BeVE1ZTBKeV80aWh6S3ZnRW83dVZ2RUY4eS05T3Z5amlCLTVpZEVYZGZlVDNieWN3Zk10blFMQld2ZnlwZEdraERJcFVEZ1lYQU9LUWdMZjRPaVhqcTVDNjd3R0k1NEJxbnVBbEZkNkxGUmc3cFFaVThS?oc=5", "source_name": "Market source", "published_at": "2025-08-16T07:00:00+00:00", "published_display": "16 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFT Pharmaceuticals profit drops despite sales up 10 percent", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPcFZoT3UwNmEydFUySWY0NWcyWk5kWlJOVjFQTFFMLTBZX1JLcF9aTFoybGRESUZ0R0tZekN4QkZwUFVTSVV2LVBLNG13UmNua3hMTkpIY1poUFl0SWNRVFYxMjVpQ2ZfVWVEdGpXQ3NDR09XejhxLTB2Z1JhX0NVcnhMWjlSVGplbE1sbm9HX1BoYXBzZVAtb2hRWVFaNWxFSE94RHBn?oc=5", "source_name": "RNZ", "published_at": "2025-05-22T07:00:00+00:00", "published_display": "22 May 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFT Pharmaceuticals [ASX:AFP] Admits to Profit Slide Yet Declares Maiden Dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQSThBTy1GVVNxWExXS09HS25GOU9rdTY1dUVfNXQwSjh4eHlialFnc0M2blZXX1QwZkc5ZVIwZEtoWTlRdHI1TFlYdlg5UXpUNmFzS1dlSmVYelA5RFJfSlgyM2ZzcXFqRmlFT1J3VmkzMU1qeUx6SmtudlNQMlFtT3B6TWxvcURwWUxlTmVFZm9GOXJwelFzcmxiQS1jbXlLNTM0Qlk1cHVJbklSOElQV0lhczFKanp1?oc=5", "source_name": "Fat Tail Daily", "published_at": "2023-05-22T07:00:00+00:00", "published_display": "22 May 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aft Pharmaceuticals Stock Price Forecast. Should You Buy AFT.NZ?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiS0FVX3lxTE1Wc0ZiTll1X3VzZkpNV25aajFyZnVNVFF2TDlnS2pvUEY5RnBvS19yXzNWVzVKSEFlMVprNFNyUFEteG9XYzAzSVdDOA?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-12T04:22:14+00:00", "published_display": "12 Dec 2020 04:22", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "AFT Pharmaceuticals' (NZSE:AFT) Profits Appear To Have Quality Issues", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solid Earnings May Not Tell The Whole Story For AFT Pharmaceuticals (NZSE:AFT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQTThja3ZIbUZOOGk3LWJQdTd5ODdZMy04cjU4YW90Qk5ndnk2ZHBtcnY4QkFiZjNKYVo5bnNPZzMyMjFwNXpWb3pUdElYNF9FR252U1gtNG5kVXRmMFdfcTY2MGlLN1laWjZ3Y3VHUXlTa2duZW9PZ19ORmpwOHNkMVhVaVVmTWhldUJQUHZrb3hqQ1dyd0tF?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Miss: AFT Pharmaceuticals Limited Missed EPS By 6.7% And Analysts Are Revising Their Forecasts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOeGNyWGVCVHcxRkdHZGNxejdxckFMZU1zYXJieHhrenBRYTZ6SExUN0lsc3NQVmc1U2hGajVrQXg2MjZlREE4ZVB2UEx6c1BReDJGZVFvZ3BfM29OUllsWGpfV1JUQ3NmbmRRZkxZWWkxS3U0ODR6RzFScU16UmZJQlVUUG5qRm5fdE4wckFnQ1RGRHJ1bUhjaWFIeGJ6X0JBRDdtX2RJNnNzZw?oc=5", "source_name": "Market source", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFT Pharmaceuticals (NZSE:AFT) EPS Rebound Tests Premium P/E And Non Cash Earnings Concerns", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFT Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We Think AFT Pharmaceuticals (NZSE:AFT) Is Well Worth Watching", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFT Pharmaceuticals lifts its 2027 revenue target to above $300 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNZ2NjRFBXMGxTVXRScjVUUmdwYjZQVl9naV9fMnFNeUh2Ynp6aXNDRXZMOWNiVXA5alZ4c2d2OGJQTlVkdEUzVTgzUjl1dmpVeGZyMGhmYnFZOHk2VEF5VkRzWHU0LXJNNlkxeXNucGhLT2pITHNlM05KNzdCSldWc0dIWlNZSUFLZzlOdnFJb1hjYzMxdHFHWEhtUUhaUmFESHFqa0NGUHpzSEVNUzEzZUJBdw?oc=5", "source_name": "RNZ", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFT Pharmaceuticals Targets Minimum $300m Revenue After Record Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOeWktbm9CTkVpVWotaFJBWkN2S3poUkNMYUQ2cVVqb3V4SzhnaGV1cER6MTI2S1FJakIwS1JjVkVEMXdaTHFyYnNQRE9tMFFBdk9JMGVCbXk2ZmhNZ0t4TWtZYm9Udk5QdEplM0ZTbE5IbzdZdGVwNFJqRXFZUFh4QXAyU0F6MWpxOUhmS0tadXpFeXZ3Z0l3UkpteU0tVU1KdTVTdlpoRGM3TXFidVE?oc=5", "source_name": "smallcaps.com.au", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFT Pharmaceuticals targets FY27 revenue above NZ$300 mln", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQQ2hqRUZ3bHZaTFNTMl80eUZUczhJQlJmQktveV9iLUNuWlEwSHA4cDQ1al9aVm5RWndGR0xlZXpwX3VUSF9UR0ttZUUxUDBSdTItNDhWazkwZS1tSDhFSG5xVnpBSS1Ia2dsWEVUQkR3S0R0dkIwblRzUm1IT2hEN3ozTVpSYTQ2bnJ1WlEzSzFVVVU4Smw1d1R4cGNPcGFrcG1CZEE1M2Y0NFJ0RGVR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFT Pharmaceuticals appoints new CFO to support global growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNeXlhM184Tk5oTHdPMmMtVHM4RUotVmJ1WWZSX1M2b3pTNWVHV3BfcUFvbmxWR29CWDVwdXdOUlFNT3ZpaGpkSDI5ZDdCVnVUUmV4aWs4cy1iSHo0MDlWNDNZcDQwU25XOUZpbUw1UEVzek5tN2dyd2hZSWxtc3hFLWVUQVR4SFhhdHJHb1k4MHlMajJFdDM5SC1QaW9pX19PMDI5dE9HYlJDOEVfOHNxNnljRnlwV0IyWVRMcGJaWnNRV2lXaUIzTnVTQXVhZ3BVX3ZiY2tyb0R5dw?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Zealand Shares Fall; AFT Pharmaceuticals Appoints CFO", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNVVVhdFVJenItU196SzNXVkkzdVVFUmFzN095OXg3TjBqTVRzRV9Kak95NjJ1VXRkQmt1R0ZIZG02TG1tQTVrRzljcTRDZGVkOV9xUkFiQkdnUWZXNkpCdXpabWhuTlFpazZIdHNHbmZtbVNYYjlIbUFwSDFvdzZWWWVLSzQ0WHdjcW13b3pQMTFDQWdTdUk1aUtFQ1ZxR2c?oc=5", "source_name": "Moomoo", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX2ZfWkxLZDAyQUZNRU55RXhPVHI4dlZrTVVuc3RlV01XV0Jqd21vSDdYU0l3QkJOejBicXhjRXhQcmpkZHlVQ3BsRFE5ZFFxbFV3MWgtLUpndEZKTm1vbTAwaGlYMHEzWVVjNDVUYjFpM1hJS0NRTjdCc3pOeG9VNlg0QThScXpuV3lYNi0xY2NXMnkwdkFMYU8xYWU0WTIyaVdESzRVV2wxaThRazh6bTZCV1RPMWpJWW0tZy1qQUJVNjh6?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why AFT Pharmaceuticals (NZSE:AFT) Has Caught The Eye Of Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPOGdCc2VHQl9hLTVQSFdPZVJEOHZuTWdvRExhWGxES3ZVOHN5XzlTaExMdVIycnRVR0FtblZIQjhtUE1pYk1RRkpKV014cFhTNmVWWkcyQ18xcnlYT01NamVMaU53NlF1eFJNek5DRENZZU0zSTFnVDdmTFFTRlBEaVJwQVZRSENIZFBWOXczSXVXNE81NlptaFJ6WnJzazBU?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and oncology therapeutics market", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPU3pvVWFDd0ZfazJEODF5YVoyWG1QTXkycFVSblVFdFRaS2RNa3JLMHFaV3JTWFhjMDZ6UEttZFk4TW1pLUxIUlBtTDNrMW9odE9wQWxMbHlsQWVDaGJMeDJNTkJ3WW82Qy1JVWcyNFRYRzB3RFlTQTgwOTQ3UHM3allGNHRVZDFYQTdXcUJmcw?oc=5", "source_name": "Market source", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is AFT Pharmaceuticals (NZSE:AFT) Using Too Much Debt?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-21T08:00:00+00:00", "published_display": "21 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Tell The Story For AFT Pharmaceuticals Limited (NZSE:AFT) As Its Stock Soars 27%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxOeWxSMzI1Zk9oQTNvQlgxUGpJUzRUcVdFRE1QNTNYQUlkdm1kS21VbWd2MU9HQURPRmMyZ3N3RUpJRllINFEwNTB2VkE4Tk1qTjNjWkczUDdjMVZnUVBQeENoMVUtdVRCNVVma3NvUDlZTVJ6TzZzVXd6Zm5zb2owcWI5ZXNkeFlwZ2poOXdub05uR0hsZWIyakRVcUU5bjZSR2t5NVZmSlQ3NUU3VlpHZHlZM1N1V0tJcmJMV281aWp3cVRDYVBoTDVQWndtMHJZOEJJbnczRUNzUU1NOTdGazFTcTBaandvLUZPMNIB8gFBVV95cUxQeWluVEJvM3VlbGdQQU9uTGFMZ0I4NGh1QjJYMW1FczhnSU9HUkFCbGJsRzdmMHl0cEtTak45d2x5N1V0dHhaNUhKMXpCT2JqNTJ1X2VKT251QjczY190TUpIek9zcV9XOV9pN21oQVY2QWZuWHZyVUlXVFIzcUt3RmQtVmFkTUVSS1cwTU4tWnNlMGFUMVduX1E5eFB4bkh5cG5JWkpJczlnTjRDWXBMZ1VQdGZ1eFhUdUo2Mi14LXBiRHktVDMwLVN0eVZKbnZYVUtsa0wwRS1FbDc1Vk5KYndiZWdKZjU3Q21JbW9YdDZkZw?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-17T07:00:00+00:00", "published_display": "17 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "69% of AFT Pharmaceuticals Limited (NZSE:AFT) is owned by insiders, and they've been buying recently", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxOVW1zVUZubzJZME5XUk1BeVE1ZTBKeV80aWh6S3ZnRW83dVZ2RUY4eS05T3Z5amlCLTVpZEVYZGZlVDNieWN3Zk10blFMQld2ZnlwZEdraERJcFVEZ1lYQU9LUWdMZjRPaVhqcTVDNjd3R0k1NEJxbnVBbEZkNkxGUmc3cFFaVThS?oc=5", "source_name": "Market source", "published_at": "2025-08-16T07:00:00+00:00", "published_display": "16 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFT Pharmaceuticals profit drops despite sales up 10 percent", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPcFZoT3UwNmEydFUySWY0NWcyWk5kWlJOVjFQTFFMLTBZX1JLcF9aTFoybGRESUZ0R0tZekN4QkZwUFVTSVV2LVBLNG13UmNua3hMTkpIY1poUFl0SWNRVFYxMjVpQ2ZfVWVEdGpXQ3NDR09XejhxLTB2Z1JhX0NVcnhMWjlSVGplbE1sbm9HX1BoYXBzZVAtb2hRWVFaNWxFSE94RHBn?oc=5", "source_name": "RNZ", "published_at": "2025-05-22T07:00:00+00:00", "published_display": "22 May 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFT Pharmaceuticals [ASX:AFP] Admits to Profit Slide Yet Declares Maiden Dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQSThBTy1GVVNxWExXS09HS25GOU9rdTY1dUVfNXQwSjh4eHlialFnc0M2blZXX1QwZkc5ZVIwZEtoWTlRdHI1TFlYdlg5UXpUNmFzS1dlSmVYelA5RFJfSlgyM2ZzcXFqRmlFT1J3VmkzMU1qeUx6SmtudlNQMlFtT3B6TWxvcURwWUxlTmVFZm9GOXJwelFzcmxiQS1jbXlLNTM0Qlk1cHVJbklSOElQV0lhczFKanp1?oc=5", "source_name": "Fat Tail Daily", "published_at": "2023-05-22T07:00:00+00:00", "published_display": "22 May 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aft Pharmaceuticals Stock Price Forecast. Should You Buy AFT.NZ?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiS0FVX3lxTE1Wc0ZiTll1X3VzZkpNV25aajFyZnVNVFF2TDlnS2pvUEY5RnBvS19yXzNWVzVKSEFlMVprNFNyUFEteG9XYzAzSVdDOA?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-12T04:22:14+00:00", "published_display": "12 Dec 2020 04:22", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 65, "total_relevant": 20, "sentiment_summary": {"positive": 6, "negative": 3, "neutral": 11, "score": 51, "total": 20, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 78, "events": [{"event": "earnings", "label": "Earnings", "weight": 5.5, "count": 10}, {"event": "general", "label": "Market update", "weight": 3.85, "count": 7}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 6, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 3.65, "latest_week": "2026-06-19", "one_week_move": -4.3, "four_week_move": -5.3, "twelve_week_move": 7.7, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.7607, "market_dynamics_buy_signal": false, "relative_strength": 8.807464, "fair_value_gap": 15.5, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 33.6238, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.3% over one week, -5.3% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 58, "badges": [], "opportunities": [], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "simplywall.st", "count": 6}, {"label": "Market source", "count": 5}, {"label": "RNZ", "count": 2}, {"label": "smallcaps.com.au", "count": 1}, {"label": "marketscreener.com", "count": 1}, {"label": "The Globe and Mail", "count": 1}, {"label": "Moomoo", "count": 1}, {"label": "AD HOC NEWS", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 20}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 10}, {"label": "Market update", "count": 7}, {"label": "Capital return", "count": 1}, {"label": "Balance sheet", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "20", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-4.3% over one week, -5.3% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "AFT Pharmaceuticals' (NZSE:AFT) Profits Appear To Have Quality Issues"}], "updated_at": "2026-06-23T04:38:24.370656+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}